Machine learning for diabetes clinical decision support: a review.
Ashwini Tuppad1, Shantala Devi Patil1
1School of Computer Science and Engineering, REVA University, Rukmini Knowledge Park, Kattigenahalli, Bangalore, Karnataka India.
Summary
Machine learning (ML) aids in managing type 2 diabetes by identifying medical gaps and improving risk assessment, diagnosis, and prognosis. This review highlights ML
Area of Science:
- Medical Informatics
- Artificial Intelligence in Healthcare
- Diabetes Research
Background:
- Type 2 diabetes is a growing epidemic with complex risk factors and serious complications.
- Lifestyle factors significantly contribute to type 2 diabetes prevalence.
- Machine learning (ML) offers potential solutions for diabetes management and clinical decision support.
Purpose of the Study:
- To review machine learning applications for type 2 diabetes prevention and management.
- To identify medical knowledge and practice gaps addressable by ML.
- To highlight future research directions in ML for diabetes care.
Main Methods:
- Review of existing literature on ML in diabetes.
- Identification of medical gaps in diabetes knowledge, guidelines, and practice.
- Categorization of ML research into risk assessment, diagnosis, and prognosis.
Main Results:
- ML can address identified medical gaps in diabetes care.
- ML research spans risk assessment, diagnosis, and prognosis of type 2 diabetes.
- Existing ML methodologies have shortcomings that require future attention.
Conclusions:
- Machine learning holds significant promise for improving type 2 diabetes prevention and management.
- Addressing identified medical and technological gaps is crucial for advancing ML in diabetes care.
- This review provides a comprehensive overview of ML applications and future directions in diabetes clinical decision support.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
424
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
424
Diabetes Mellitus: Overview and Type I Subtype
3.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.4K
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Diabetes: Symptoms, Diagnosis, and Complications
813
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
813
Pathophysiology of Diabetes
1.4K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.4K
Classification of Illness
8.0K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
8.0K


